FDA Inspection 1209415 — Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd
The FDA completed an inspection of Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd on June 2, 2023 in Jinhua. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 2, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Jinhua (China)